Detalhe da pesquisa
1.
Early, precise, and safe clinical evaluation of the pharmacodynamic effects of novel agents in the intact human tumor microenvironment.
Front Pharmacol
; 15: 1367581, 2024.
Artigo
Inglês
| MEDLINE | ID: mdl-38681192
2.
Voruciclib, a clinical stage oral CDK9 inhibitor, represses MCL-1 and sensitizes high-risk Diffuse Large B-cell Lymphoma to BCL2 inhibition.
Sci Rep
; 7(1): 18007, 2017 12 21.
Artigo
Inglês
| MEDLINE | ID: mdl-29269870